SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: molemania who wrote (318)12/31/1997 5:07:00 PM
From: swoboda4  Respond to of 675
 
Any positive news such as a new study or tests for another product should move this stock north. All of the bad news is out and a little public relations work or "hype" will help the current stockholders. Happy New Year to all CNSI investors.



To: molemania who wrote (318)12/31/1997 5:15:00 PM
From: NeuroInvestment  Read Replies (2) | Respond to of 675
 
No. Any market screen that looks at book value would immediately label this as a rare biotech selling for less than cash, which could put it on some peoples 1998 buy lists completely separate from any R&D value.That same fact also makes it an acquisition possibility..
NeuroInvestment


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News